Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

288
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
288
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

390
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
390
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

412
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
412
Observational Studies01:11

Observational Studies

11.2K
Observational studies are a type of analytical study where researchers observe events without any interventions. In other words, the researcher does not influence the response variable or the experiment's outcome.
There are three types of observational studies – Prospective, retrospective, and cross-sectional.
Prospective Study
Prospective studies, also known as longitudinal or cohort studies, are carried out by collecting future data from groups sharing similar characteristics. One...
11.2K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

233
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
233
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

569
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
569

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a BMU-on-a-chip model based on spatiotemporal regulation of cellular interactions in the bone remodeling cycle.

Materials today. Bio·2025
Same author

Association between urine creatinine excretion and bone mineral density in chronic kidney disease: Results from the KNOW-CKD study.

Journal of nephrology·2024
Same author

Statin Use and the Progression of Coronary Artery Calcification in CKD: Findings From the KNOW-CKD Study.

Kidney international reports·2024
Same author

A long-term storable gel-laden chip composite built in a multi-well plate enabling<i>in situ</i>cell encapsulation for high-throughput liver model.

Biofabrication·2024
Same author

A Simple Laser-Induced Breakdown Spectroscopy Method for Quantification and Classification of Edible Sea Salts Assisted by Surface-Hydrophilicity-Enhanced Silicon Wafer Substrates.

Sensors (Basel, Switzerland)·2023
Same author

Feasibility of a Low-Power, Low-Resolution Laser-Induced Breakdown Spectroscopy Instrument for Analysis of Nickel Alloys: Quantification of the Major Alloying Elements and Classification.

Applied spectroscopy·2023

Related Experiment Video

Updated: Feb 17, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

A simulation study on implementing marginal structural models in an observational study with switching medication

Hyang Kim1, Greg Cable1

  • 1a Biostatistics , PAREXEL International , Billerica , MA , USA.

Journal of Biopharmaceutical Statistics
|December 5, 2017
PubMed
Summary

Estimating treatment effectiveness is challenging with patient treatment switching, especially when biomarkers introduce time-varying confounding. Simulation studies reveal severe bias when using marginal structural models with multiple switches, measurement error, and missing data.

Keywords:
Causal inferenceconfoundingdirected acyclic graphmarginal structural modelmeasurement errorsobservational studyselection biasswitching medication

More Related Videos

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.5K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K

Related Experiment Videos

Last Updated: Feb 17, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.5K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

11.2K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Health Informatics

Background:

  • Assessing treatment effectiveness in longitudinal studies is complex due to non-randomized treatment assignments and patient treatment switching.
  • Time-varying confounding, influenced by prior exposure and affecting subsequent treatment, complicates treatment effect estimation.
  • Precision medicine utilizes biomarkers, but these can introduce time-varying confounding, measurement errors, and impact treatment switching decisions.

Purpose of the Study:

  • To investigate the impact of medication switching based on biomarkers on treatment effectiveness evaluation.
  • To explore biased estimation in longitudinal data analysis under various confounding scenarios.
  • To assess the performance of marginal structural models in the presence of complex confounding factors.

Main Methods:

  • Conducted simulation studies to evaluate biased estimation under different scenarios.
  • Employed marginal structural models for analyzing longitudinal data with treatment switching.
  • Held model misspecification constant to isolate the effects of confounding, measurement error, and missing data.

Main Results:

  • Severe bias in treatment effect estimation was observed in the presence of multiple treatment switches.
  • Measurement error and missing data in covariates exacerbated the bias.
  • The interplay of time-varying confounding from biomarkers and treatment switching significantly impacts analysis.

Conclusions:

  • Marginal structural models may yield severely biased results when analyzing longitudinal data with frequent treatment switching, biomarker-driven changes, measurement error, and missing covariate data.
  • The complexity introduced by time-varying confounding, particularly from biomarkers, requires careful consideration in treatment effectiveness studies.
  • Further research is needed to develop robust methods for handling these challenges in real-world clinical data analysis.